By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Axial Biotherapeutics 

Prudential Center
800 Boylston Street,15th Floor
Boston  Massachusetts  02199  U.S.A.
Phone: n/a Fax: n/a


Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders.


November 2016


Co-Founder, CEO and Director: David H. Donabedian, Ph.D.

Co-Founder and Director: Sarkis Mazmanian, Ph.D.

Key Statistics

Ownership: Private

Web Site: Axial Biotherapeutics

Company News
Axial Biotherapeutics Announces Appointment Of Srinivas G. Rao, M.D., Ph.D., As Chief Medical Officer 8/22/2017 7:16:54 AM
Axial Biotherapeutics Makes Inaugural Appointments To Its Scientific And Clinical Advisory Board 7/12/2017 10:57:23 AM
Axial Biotherapeutics To Host Workshop Highlighting Advances In Gut Microbiome-Brain Connections 6/27/2017 6:36:39 AM
Axial Biotherapeutics Expands Board Of Directors With Appointments Of Independent Members Ronald C. Renaud Jr. And Henry C. (“Hank”) Wolf 4/26/2017 6:47:01 AM
Axial Biotherapeutics Release: Biotech Expands Management Team To Strengthen Financial Operations And Accelerate Clinical Development 1/19/2017 7:38:42 AM
Axial Biotherapeutics Announces The Groundbreaking Discovery Of A Biological Link Between The Gut Microbiome And Parkinson’s Disease Published In Cell 12/1/2016 11:17:51 AM